ITU Unit Action

BACTINE

WellSpring Pharmaceutical Corporation

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 90017949 FILING DATE 06/24/2020
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY JOHNSON, AISHA CLARKE
L.O. ASSIGNED 101

PUB INFORMATION

RUN DATE 03/31/2021
PUB DATE 11/03/2020
STATUS 748-STATEMENT OF USE - TO EXAMINER
STATUS DATE 03/30/2021
LITERAL MARK ELEMENT BACTINE

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT BACTINE
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME WellSpring Pharmaceutical Corporation
ADDRESS 5911 N. HONORE AVENUE, SUITE 211
Sarasota, FL 34243
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Hydrogel for medical purposes

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE 02/18/2021 FIRST USE IN COMMERCE DATE 02/18/2021 CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
OWNER OF US REG NOS 0525085    2504774    5843473   

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
03/30/2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE 014
03/09/2021 IUAF S USE AMENDMENT FILED 013
03/29/2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL 012
03/09/2021 EISU I TEAS STATEMENT OF USE RECEIVED 011
12/30/2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 010
11/03/2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 009
11/03/2020 PUBO A PUBLISHED FOR OPPOSITION 008
10/14/2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 007
09/26/2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 006
09/26/2020 DOCK D ASSIGNED TO EXAMINER 005
08/04/2020 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED 004
08/04/2020 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED 003
07/21/2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
06/27/2020 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Kurt E. Anderson
CORRESPONDENCE ADDRESS Kurt E. Anderson
GIORDANO, HALLERAN & CIESLA, P.C.
GIORDANO, HALLERAN & CIESLA,
125 HALF MILE ROAD, SUITE 300
RED BANK, NJ 07701
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME WellSpring Pharmaceutical Corporation
ADDRESS 5911 N. HONORE AVENUE, SUITE 211
Sarasota, FL 34243
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed